NVP 018
Alternative Names: BC-556; NVP-018; OCB-030Latest Information Update: 11 Sep 2024
At a glance
- Originator Biotica Technology
- Developer Abliva
- Class Antivirals; Polyketides
- Mechanism of Action Cyclophilin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Hepatitis B